Nimotuzumab abrogates acquired radioresistance of KYSE-150R...

  • Main
  • 2015 / 02
  • Nimotuzumab abrogates acquired radioresistance of KYSE-150R...
OncoTargets and Therapy 2015 / 02

Nimotuzumab abrogates acquired radioresistance of KYSE-150R esophageal cancer cells by inhibiting EGFR signaling and cellular DNA repair

Liu, Hai, Yang, Weifang, Gao, Huaping, Jiang, Tingting, Gu, Bengxin, Dong, Qinghua, Xu, Wenhong, Wu, Shixiu, Sun, Xiaonan
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
OncoTargets and Therapy
DOI:
10.2147/OTT.S76958
Date:
February, 2015
File:
PDF, 2.85 MB
english, 2015
Conversion to is in progress
Conversion to is failed